Loading...

Skip to main content

Call us on + 1 (800) 604-9114 for more information about our products

Looking for specific datasheet Manual/COA/MSDS?
Request a Manual/COA/MSDS

Interested to get a quote about our products?
Request a Quote

Western Blot (WB) (Western Blot analysis of total cell lysates from HCT15, DLD1 and mouse thymocytes using MBS608415.)

Rabbit Lymphoid Enhancer Factor 1 Monoclonal Antibody | anti-LEF1 antibody

Lymphoid Enhancer Factor 1 (LEF1, Lymphoid Enhancer-binding Factor 1, DKFZp586H0919, HGNC:6551, T cell Specific Transcription Factor 1 alpha, TCF1 alpha)

Gene Names
LEF1; LEF-1; TCF10; TCF7L3; TCF1ALPHA
Reactivity
Human, Mouse, Rat
Applications
Western Blot, Immunoprecipitation, Immunocytochemistry, Flow Cytometry, Functional Assay, Immunofluorescence
Purity
Supernatant
Supernatant
Synonyms
Lymphoid Enhancer Factor 1; Monoclonal Antibody; Lymphoid Enhancer Factor 1 (LEF1; Lymphoid Enhancer-binding Factor 1; DKFZp586H0919; HGNC:6551; T cell Specific Transcription Factor 1 alpha; TCF1 alpha); Anti -Lymphoid Enhancer Factor 1 (LEF1; anti-LEF1 antibody
Ordering
For Research Use Only!
Host
Rabbit
Reactivity
Human, Mouse, Rat
Clonality
Monoclonal
Isotype
IgG
Clone Number
7H38
Specificity
Recognizes endogenous level of total human LEF1 protein at ~25-58kD. Does not recognize the dominant negative forms of LEF1 generated by an alternative promoter.
Purity/Purification
Supernatant
Supernatant
Form/Format
Supplied as a liquid in 10mM sodium HEPES, pH 7.5, 150mM sodium chloride, 0.1mg/ml BSA, < 0.02% sodium azide, 50% glycerol.
Applicable Applications for anti-LEF1 antibody
Western Blot (WB), Immunoprecipitation (IP), Immunocytochemistry (ICC), Flow Cytometry (FC/FACS), Immunofluorescence (IF)
Application Notes
Suitable for use in Western Blot, Immunoprecipitation, Flow Cytometry, Immunofluorescence and Immunocytochemistry.
Dilution: Western Blot: 1:1000. Incubate membrane with diluted antibody in 1X TBS, 5% BSA, 0.1% Tween-20 at 4ºC with gentle shaking, overnight.
Immunoprecipitation: 1:50
Flow Cytometry: 1:200
Immunofluorescence (IF-IC): 1:100
Immunogen
Synthetic peptide corresponding to residues surrounding Pro82 of human LEF1.
Preparation and Storage
May be stored at 4 degree C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Western Blot (WB)

(Western Blot analysis of total cell lysates from HCT15, DLD1 and mouse thymocytes using MBS608415.)

Western Blot (WB) (Western Blot analysis of total cell lysates from HCT15, DLD1 and mouse thymocytes using MBS608415.)

Flow Cytometry (FC/FACS)

(Flow cytometric analysis of untreated Jurkat cells using MBS608415 (blue) compared to a nonspecific negative control antibody (red).)

Flow Cytometry (FC/FACS) (Flow cytometric analysis of untreated Jurkat cells using MBS608415 (blue) compared to a nonspecific negative control antibody (red).)

Immunofluorescence (IF)

(Confocal immunofluorescent analysis of HCT-15 cells using MBS608415 (green) and Pan-Keratin Mouse mAb (red).)

Immunofluorescence (IF) (Confocal immunofluorescent analysis of HCT-15 cells using MBS608415 (green) and Pan-Keratin Mouse mAb (red).)
Related Product Information for anti-LEF1 antibody
LEF1/TCF are members of the high mobility group (HMG) DNA binding protein family of transcription factors which consists of four members: Lymphoid enhancer factor 1 (LEF1), T Cell Factor 1 (TCF1), TCF3 and TCF4 (1). LEF1 and TCF1 were originally identified as important factors regulating early lymphoid development (2) and are downstream factors in the Wnt signaling pathway. LEF1/TCF bind to Wnt response elements to provide a docking site for beta-catenin which translocates to the nucleus and promotes the transcription of target genes upon activation of Wnt signaling (3). LEF1/TCF proteins are dynamically expressed during development and aberrant activation of the Wnt signaling pathway is involved in many types of cancers such as colon cancers (4,5).
Product Categories/Family for anti-LEF1 antibody

NCBI and Uniprot Product Information

NCBI GI #
NCBI GeneID
NCBI Accession #
NCBI GenBank Nucleotide #
UniProt Accession #
Molecular Weight
44,201 Da
NCBI Official Full Name
lymphoid enhancer-binding factor 1 isoform 1
NCBI Official Synonym Full Names
lymphoid enhancer-binding factor 1
NCBI Official Symbol
LEF1
NCBI Official Synonym Symbols
LEF-1; TCF10; TCF7L3; TCF1ALPHA
NCBI Protein Information
lymphoid enhancer-binding factor 1; TCF1-alpha; T cell-specific transcription factor 1-alpha
UniProt Protein Name
Lymphoid enhancer-binding factor 1
UniProt Gene Name
LEF1
UniProt Synonym Gene Names
LEF-1; TCF1-alpha
UniProt Entry Name
LEF1_HUMAN

NCBI Description

This gene encodes a transcription factor belonging to a family of proteins that share homology with the high mobility group protein-1. The protein encoded by this gene can bind to a functionally important site in the T-cell receptor-alpha enhancer, thereby conferring maximal enhancer activity. This transcription factor is involved in the Wnt signaling pathway, and it may function in hair cell differentiation and follicle morphogenesis. Mutations in this gene have been found in somatic sebaceous tumors. This gene has also been linked to other cancers, including androgen-independent prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]

Uniprot Description

LEF-1: a transcription factor of the TCF/LEF family. Participates in the Wnt signaling pathway and regulates T-cell receptor alpha-C enhancer function. Activates transcription of target genes in the presence of CTNNB1 and EP300. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by LEF1 and CTNNB1. Binds DNA in a sequence-specific manner. PIAG antagonizes both Wnt-dependent and Wnt-independent activation by LEF1. Deletions in LEF1 have been observed in a subset of pre-B-cell acute lymphoblastic leukemia (B-ALL) cases. Four human isoforms produced by alternative promoter usage and alternative splicing have been described. Isoform 3 lacks the CTNNB1 interaction domain and may be an antagonist for Wnt signaling.

Protein type: DNA-binding; Transcription factor

Chromosomal Location of Human Ortholog: 4q23-q25

Cellular Component: nucleoplasm; transcription factor complex; cytoplasm; nucleus

Molecular Function: RNA polymerase II transcription factor activity, enhancer binding; estrogen receptor activity; histone binding; caspase inhibitor activity; beta-catenin binding; transcription factor binding; protein binding; DNA binding; sequence-specific DNA binding; gamma-catenin binding; estrogen receptor binding; chromatin binding; transcription factor activity; DNA bending activity

Biological Process: transcription from RNA polymerase II promoter; B cell proliferation; negative regulation of interleukin-4 production; tongue development; radial glial cell differentiation in the forebrain; hypothalamus development; paraxial mesoderm formation; positive regulation of transcription, DNA-dependent; positive regulation of granulocyte differentiation; T-helper 1 cell differentiation; alpha-beta T cell differentiation; negative regulation of transcription from RNA polymerase II promoter; Wnt receptor signaling pathway through beta-catenin; negative regulation of caspase activity; palate development; forebrain neuroblast division; anatomical structure regression; forebrain neuron differentiation; BMP signaling pathway; negative regulation of interleukin-13 production; regulation of cell-cell adhesion; mammary gland development; positive regulation of cell proliferation; positive regulation of cell-cell adhesion; muscle fiber development; neural crest cell migration; embryonic limb morphogenesis; regulation of striated muscle development; somitogenesis; Wnt receptor signaling pathway; dentate gyrus development; sensory perception of taste; neutrophil differentiation; negative regulation of striated muscle development; positive regulation of cell growth; negative regulation of DNA binding; odontogenesis of dentine-containing teeth; osteoblast differentiation; patterning of blood vessels; formation of radial glial scaffolds; T cell receptor V(D)J recombination; epithelial to mesenchymal transition; negative regulation of interleukin-5 production; positive regulation of transcription from RNA polymerase II promoter; steroid hormone mediated signaling; negative regulation of cell-cell adhesion; sprouting angiogenesis; negative regulation of transcription, DNA-dependent; eye pigmentation; negative regulation of apoptosis; positive regulation of cell migration

Research Articles on LEF1

Similar Products

Product Notes

The LEF1 lef1 (Catalog #AAA608415) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Lymphoid Enhancer Factor 1 (LEF1, Lymphoid Enhancer-binding Factor 1, DKFZp586H0919, HGNC:6551, T cell Specific Transcription Factor 1 alpha, TCF1 alpha) reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. AAA Biotech's Lymphoid Enhancer Factor 1 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunoprecipitation (IP), Immunocytochemistry (ICC), Flow Cytometry (FC/FACS), Immunofluorescence (IF). Suitable for use in Western Blot, Immunoprecipitation, Flow Cytometry, Immunofluorescence and Immunocytochemistry. Dilution: Western Blot: 1:1000. Incubate membrane with diluted antibody in 1X TBS, 5% BSA, 0.1% Tween-20 at 4ºC with gentle shaking, overnight. Immunoprecipitation: 1:50 Flow Cytometry: 1:200 Immunofluorescence (IF-IC): 1:100. Researchers should empirically determine the suitability of the LEF1 lef1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "Lymphoid Enhancer Factor 1, Monoclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.

Precautions

All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.

Disclaimer

Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.

Item has been added to Shopping Cart

If you are ready to order, navigate to Shopping Cart and get ready to checkout.

Looking for a specific manual?
Request a Manual

Request more Information

Please complete the form below and a representative will contact you as soon as possible.

Request a Manual

Please complete the form below and a representative will contact you as soon as possible.

Request a Quote

Please complete the form below and a representative will contact you as soon as possible.